Cover Image

Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator

Cheung-Ter Ong,1,2 Yi-Sin Wong,3 Chi-Shun Wu,1 Yu-Hsiang Su1 1Department of Neurology, Chia-Yi Christian Hospital, 2Department of Nursing, Chung Jen Junior College of Nursing, Health Science and Management, 3Department of Family Medicine, Chia-Yi Christian Hospital, Chia-Yi, Taiwan Background and pu...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ong CT (Author), Wong YS (Author), Wu CS (Author), Su YH (Author)
Format:	Book
Published:	Dove Medical Press, 2017-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Impact of Loading Dose on Outcome in Stroke Patients Receiving Low-Dose Tissue Plasminogen Activator Thrombolytic Therapy
by: Wong YS, et al.
Published: (2020)

Atrial fibrillation is a predictor of in-hospital mortality in ischemic stroke patients
by: Ong CT, et al.
Published: (2016)

Neutrophilic noncoding RNAs predict outcomes of acute ischemic stroke patients treated with recombinant tissue plasminogen activator
by: Ziping Han, et al.
Published: (2022)

Enzymatic vitreolysis with recombinant tissue plasminogen activator for vitreomacular traction
by: Raczyńska D, et al.
Published: (2015)

Outcome after systemic thrombolysis is predicted by age and stroke severity: an open label experience with recombinant tissue plasminogen activator and tirofiban
by: Rudiger J. Seitz, et al.
Published: (2012)

Does intravenous administration of recombinant tissue plasminogen activator for ischemic stroke can cause inferior myocardial infarction?
by: Mostafa Almasi, et al.
Published: (2016)

The Utility of Automated ASPECTS in Acute Ischemic Stroke for Intravenous Recombinant Tissue Plasminogen Activator (IV-rtPA) Therapy
by: Soichiro Shibata, et al.
Published: (2022)

Role of Tissue-Type Plasminogen Activator in Ischemic Stroke
by: Yasuhiro Suzuki
Published: (2010)

Stability of Recombinant Tissue Plasminogen Activator at −30 °C over One Year
by: Abdulmalik Alkatheri
Published: (2013)

Evaluation of Children Receiving Tissue Plasminogen Activator Therapy for Thrombosis: Single Center Experience
by: Ahmet Yöntem, et al.
Published: (2021)

Emergency nurses\' knowledge and adherence to tissue plasminogen activator guidelines for patients with stroke
by: Elnaz Asghari, et al.
Published: (2024)

Factors affecting improvement after intravenous administration of recombinant tissue plasminogen activator (rtPA) among patients with acute ischemic stroke: A historical cohort study
by: Seyed mohammad Masood Hojjati, et al.
Published: (2024)

Thrombus attached to suture materials successfully thrombolysed with low-dose tissue plasminogen activator
by: Macit Kalçık, et al.
Published: (2014)

Drug Dependence, Synaptic Plasticity, and Tissue Plasminogen Activator
by: Kiyofumi Yamada, et al.
Published: (2005)

Tissue Plasminogen Activator Is Not Involved in Methamphetamine-Induced Neurotoxicity
by: Ayumi Fukakusa, et al.
Published: (2008)

Tissue plasminogen activator for a rare case of neonatal empyema
by: A.B. Montgomery, et al.
Published: (2020)

QiShenYiQi Inhibits Tissue Plasminogen Activator-Induced Brain Edema and Hemorrhage after Ischemic Stroke in Mice
by: Yang Ye, et al.
Published: (2022)

Altered Gene Expression in an Embolic Stroke Model After Thrombolysis With Tissue Plasminogen Activator and Stachybotrys microspora Triprenyl Phenol-7
by: Terumasa Hashimoto, et al.
Published: (2014)

The Protective Role of Immunomodulators on Tissue-Type Plasminogen Activator-Induced Hemorrhagic Transformation in Experimental Stroke: A Systematic Review and Meta-Analysis
by: Yang Ye, et al.
Published: (2020)

Tissue-plasminogen activator effects on the phenotype of splenic myeloid cells in acute inflammation
by: Célia Seillier, et al.
Published: (2024)

Combined Treatment With 2-(2-Benzofu-Ranyl)-2-Imidazoline and Recombinant Tissue Plasminogen Activator Protects Blood-Brain Barrier Integrity in a Rat Model of Embolic Middle Cerebral Artery Occlusion
by: Linlei Zhang, et al.
Published: (2020)

Comparison of the effect of two different doses of recombinant gonadotropin for ovarian stimulation on the outcome of intrauterine insemination
by: Ming-Ting Chung, et al.
Published: (2011)

Novel Situations of Endothelial Injury in Stroke - Mechanisms of Stroke and Strategy of Drug Development: Intracranial Bleeding Associated With the Treatment of Ischemic Stroke: Thrombolytic Treatment of Ischemia-Affected Endothelial Cells With Tissue-Type Plasminogen Activator
by: Yasuhiro Suzuki, et al.
Published: (2011)

Treatment of thrombosis in KD Patients using tissue plasminogen activator: a single center study
by: Yanqiu Chu, et al.
Published: (2022)

Premature delivery impacts the concentration of plasminogen activators and a plasminogen activator inhibitor and the plasmin activity in human milk
by: Veronique Demers-Mathieu, et al.
Published: (2022)

The Role of the Plasminogen Activating System in Neurobiology
by: Robert L. Medcalf
Published: (2017)

Inhibition of Pathological Retinal Neovascularization by a Small Peptide Derived from Human Tissue-Type Plasminogen Kringle 2
by: Qian Sun, et al.
Published: (2020)

A serial fluoroscopy-guided thrombolytic therapy of a mechanical tricuspid prosthetic valve thrombosis with low-dose and ultra-slow infusion of tissue-type plasminogen activator
by: Macit Kalcik, et al.
Published: (2014)

A case of renal artery embolism treated by selective intra-arterial infusion of tissue plasminogen activator
by: Onur Baydar, et al.
Published: (2013)

Enoxaparin Effect on Pregnancy Outcomes in a Patient with Elevated Plasminogen Activator Inhibitor-1
by: Kathleen Minor, et al.
Published: (2020)

Intravenous thrombolysis with rt-plasminogen activator in patients with acute ischemic stroke: clinical experience from two Egyptian centers
by: Nabil Mohamed, et al.
Published: (2020)

Acute, massive pulmonary embolism with right heart strain and hypoxia requiring emergent tissue plasminogen activator (TPA) infusion
by: Jonathan Patane, et al.
Published: (2017)

Preparation of ultrasound microbubbles crosslinked to albumin nanoparticles packaged with tissue-type plasminogen activator gene plasmid and method of in vivo transfection
by: Jun J, et al.
Published: (2011)

Immunohistochemical expression of plasminogen activator inhibitor-1 in subcutaneous versus omental adipose tissue in patients after elective abdominal surgery
by: Mehmet Yildiz, et al.
Published: (2019)

Upregulation of Plasminogen Activator Inhibitor-1 in Irradiated Recipient Arteries and Veins from Free Tissue Transfer Reconstruction in Cancer Patients
by: Bjorn O. Eriksson, et al.
Published: (2018)

Assessment of plasminogen activator inhibitor-1 in obese Egyptian children
by: Marwa Farouk Mira, et al.
Published: (2020)

Optimization of expression yield in a stable cell line expressing a novel mutated chimeric tissue plasminogen activator (mt-PA)
by: Mozhgan Raigani, et al.
Published: (2022)

Effect of Progesterone on Expression of Prostaglandin Synthases and Plasminogen Activator in Bovine Endometrium during Estrous Cycle
by: Su-Bin Choi, et al.
Published: (2016)

Immunohistochemical study of the plasminogen activator system in benign epithelial odontogenic lesions
by: Carla Samily de Oliveira Costa, et al.
Published: (2022)

Expression of plasminogen activators in preimplantation rat embryos developed <it>in vivo </it>and <it>in vitro</it>
by: Har-Vardi Iris, et al.
Published: (2005)